Page last updated: 2024-10-30

lomerizine and Vertigo

lomerizine has been researched along with Vertigo in 1 studies

lomerizine: used to treat migraines

Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)

Research Excerpts

ExcerptRelevanceReference
"Lomerizine, a calcium channel blocker, may be effective as a treatment for migraine-associated vertigo (MAV)."9.12Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. ( Chihara, Y; Ito, K; Iwasaki, S; Murofushi, T; Sugasawa, K; Ushio, M, 2007)
"Lomerizine, a calcium channel blocker, may be effective as a treatment for migraine-associated vertigo (MAV)."5.12Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. ( Chihara, Y; Ito, K; Iwasaki, S; Murofushi, T; Sugasawa, K; Ushio, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwasaki, S1
Ushio, M1
Chihara, Y1
Ito, K1
Sugasawa, K1
Murofushi, T1

Trials

1 trial available for lomerizine and Vertigo

ArticleYear
Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist.
    Acta oto-laryngologica. Supplementum, 2007, Issue:559

    Topics: Adolescent; Adult; Asian People; Calcium Channel Blockers; Evoked Potentials; Female; Humans; Male;

2007